We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$9.86B
AUM Growth
-$803M
(-7.5%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
2.79%
Top 10 Holdings %
Top 10 Hldgs %
30.57%
Holding
177
New
20
Increased
25
Reduced
25
Closed
19
Top Buys
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$123M |
| 2 |
Neuropace
NPCE
|
+$93.1M |
| 3 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$77.8M |
| 4 |
Janux Therapeutics
JANX
|
+$77.2M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$74.2M |
Top Sells
| 1 |
Haemonetics
HAE
|
+$94.6M |
| 2 |
AbCellera Biologics
ABCL
|
+$54.5M |
| 3 |
ADVM
Adverum Biotechnologies
ADVM
|
+$54.2M |
| 4 |
Molina Healthcare
MOH
|
+$38M |
| 5 |
PAND
Pandion Therapeutics Inc. Common Stock
PAND
|
+$31.7M |
Sector Composition
| 1 | Healthcare | 95.36% |
| 2 | Technology | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cullinan Oncology
CGEM
$1.09B
| $29.5M | 0.3% |
1,146,145
| – | – |
|
|
SCPH
77
DELISTED
scPharmaceuticals
SCPH
| $29.3M | 0.3% |
4,797,148
| – | – |
|
78
KALA BIO
KALA
$20.1M
| $29M | 0.29% |
2,188
| – | – |
|
|
SRRA
79
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $28.8M | 0.29% |
1,477,320
| – | – |
|
80
Standard BioTools
LAB
$335M
| $28.7M | 0.29% |
4,661,871
+62,300
| +1% | +$333K |
|
81
Arcturus Therapeutics
ARCT
$182M
| $28.7M | 0.29% |
848,503
-358,383
| -30% | -$12.1M |
|
82
Curis
CRIS
$9.06M
| $28.4M | 0.29% |
8,804
-2,112
| -19% | -$9.54M |
|
83
Spyre Therapeutics
SYRE
$8.67B
| $27.9M | 0.28% |
160,621
| – | – |
|
|
ALXN
84
DELISTED
Alexion Pharmaceuticals
ALXN
| $27.7M | 0.28% |
150,900
+48,800
| +48% | +$8.38M |
|
|
ALPN
85
DELISTED
Alpine Immune Sciences Inc
ALPN
| $27.6M | 0.28% |
3,070,955
| – | – |
|
|
APTO
86
DELISTED
Aptose Biosciences, Inc.
APTO
| $26.7M | 0.27% |
17,844
| – | – |
|
|
FUSN
87
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $26.1M | 0.26% |
3,224,770
| – | – |
|
88
Xenon Pharmaceuticals
XENE
$6.51B
| $24.8M | 0.25% |
1,334,217
-1,163,700
| -47% | -$21.5M |
|
89
Biogen
BIIB
$28.9B
| $23.3M | 0.24% |
67,400
-14,600
| -18% | -$4.42M |
|
|
FLXN
90
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $22.8M | 0.23% |
2,769,383
+461,300
| +20% | +$3.92M |
|
91
CalciMedica
CALC
$12.2M
| $22.6M | 0.23% |
297,382
| – | – |
|
92
Olema Pharmaceuticals
OLMA
$1.05B
| $22.6M | 0.23% |
807,792
+151,666
| +23% | +$4.32M |
|
93
NextCure
NXTC
$24.6M
| $21.8M | 0.22% |
225,918
| – | – |
|
94
Corvus Pharmaceuticals
CRVS
$1.26B
| $21.5M | 0.22% |
8,053,298
| – | – |
|
95
Enliven Therapeutics
ELVN
$3.72B
| $21.5M | 0.22% |
679,976
| – | – |
|
96
Vaxcyte
PCVX
$8.16B
| $21.3M | 0.22% |
945,400
+296,626
| +46% | +$6.07M |
|
|
DMRA
97
Damora Therapeutics
DMRA
$1.9B
| $20.7M | 0.21% |
163,637
| – | – |
|
98
Dianthus Therapeutics
DNTH
$5.47B
| $19.9M | 0.2% |
127,110
+67,794
| +114% | +$12.5M |
|
99
Gilead Sciences
GILD
$164B
| $19.8M | 0.2% |
287,600
| – | – |
|
|
KDNY
100
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18.8M | 0.19% |
1,333,801
+83,800
| +7% | +$1.34M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM